CHRISTOPHER VOLTURO: Open Payments
NPI 1346522687 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,136 in 60 payments from 18 companies in 2025. Trend: 2023 $381 · 2024 $409 · 2025 $1,136
Food & beverage: $1,037Education: $99
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $165 |
| Astellas Pharma US Inc | 3 | $145 |
| Novo Nordisk Inc | 10 | $143 |
| Lilly USA, LLC | 9 | $129 |
| Axsome Therapeutics, Inc. | 5 | $106 |
| ABBVIE INC. | 4 | $94 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 4 | $58 |
| Philips North America LLC | 1 | $41 |
| Exact Sciences Corporation | 2 | $33 |
Products named: MOUNJARO, NURTEC ODT, QULIPTA, Ozempic, ELIQUIS, NEFFY, Auvelity, Veozah.
Industry payments across FL — which companies pay providers there.
